Larimar Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Bala Cynwyd, PA
LRMR chart
What traders are saying about $LRMR
Latest postsLarimar Therapeutics, Inc. news
- LRMR Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts Shares 3.52% - Earnings Cycle Report
https://www.dars.gov.et/ ·
- Larimar Therapeutics, Inc. Estimates – NASDAQ:LRMR
TradingView ·
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
marketbeat.com ·
- Larimar (LRMR) Loses 22.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Yahoo Finance ·
- Larimar Therapeutics Strengthens Executive Leadership with Appointment of John Harlow as President and Chief Operating Officer
Yahoo Finance ·
- 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Yahoo Finance ·
- Century Therapeutics Appoints Joseph Truitt to Board of Directors
Yahoo Finance ·
- Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Yahoo Finance ·
- Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy
Yahoo Finance ·
- LRMR Stock Edges Up After Hours After Director Purchases Shares Worth About $167,000
stocktwits.com ·
- Here’s What Citi Thinks About Larimar Therapeutics (LRMR)
Yahoo Finance ·
- LRMR Shares Hold Steady As Wall Street Optimism Offsets Drug Safety Concerns
stocktwits.com ·
Larimar Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$165.7M | -$80.6M | -$36.9M | -$35.4M |
| Diluted EPS | – | $-1.32 | $-0.84 | $-1.37 |
| Total assets (year end) | $145.8M | $200.2M | $95.9M | $126.4M |
| Cash and equivalents (year end) | $85.4M | $33.2M | $26.7M | $26.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Larimar Therapeutics, Inc.
- Ticker
- LRMR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bala Cynwyd, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1374690
- Former names
- ZAFGEN, INC., ZAFGEN INC
Frequently asked questions
What exchange is Larimar Therapeutics, Inc. listed on?
Larimar Therapeutics, Inc. trades on the Nasdaq under the ticker symbol LRMR.
What industry is Larimar Therapeutics, Inc. in?
Larimar Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Larimar Therapeutics, Inc. headquartered?
Larimar Therapeutics, Inc.'s business address on file with the SEC is in Bala Cynwyd, PA.
When does Larimar Therapeutics, Inc.'s fiscal year end?
Larimar Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Larimar Therapeutics, Inc. report?
Larimar Therapeutics, Inc. reported $0 in revenue for calendar year 2019, according to its SEC filings.